Market capitalization is the total value the stock market puts on a company: its share price multiplied by the number of shares outstanding. Each point here is the share count reported in a filing multiplied by the closing price on that filing date, adjusted for later stock splits, so the history moves when a new filing arrives rather than with each day's trading. A larger market cap means investors collectively value the company more highly; by itself it says nothing about profit or debt. Annual points keep the latest observation in each calendar year.
Aligos Therapeutics, Inc. market cap for the quarter ending 2026-06-30 was $35.77M, a 19.96% decline year-over-year.
Aligos Therapeutics, Inc. market cap for the quarter ending 2026-03-31 was $45.92M, a 8.98% decline year-over-year.
Aligos Therapeutics, Inc. market cap for the quarter ending 2025-12-31 was $58.2M, a 62.20% decline year-over-year.
Aligos Therapeutics, Inc. market cap for the quarter ending 2025-09-30 was $59.75M, a 107.52% increase year-over-year.
Aligos Therapeutics, Inc. market cap for fiscal 2026 was $35.77M.
Aligos Therapeutics, Inc. market cap for fiscal 2025 was $58.2M, a 62.20% decline from fiscal 2024.
Aligos Therapeutics, Inc. market cap for fiscal 2024 was $153.96M, a 208.76% increase from fiscal 2023.
Aligos Therapeutics, Inc. market cap for fiscal 2023 was $49.86M, a 95.12% decline from fiscal 2022.